MARATHON VENTURE PARTNERS

MARATHON VENTURE PARTNERS was founded in 2016 as an early-stage venture capital fund focused on the digital healthcare sector. Currently, MARATHON manages RMB and USD funds totaling 1 billion RMB, while also raising a second phase of RMB and USD funds with a target size of 2 billion RMB. Guided by consumer upgrades, technological applications, and changes in industrial policies, we aim to build the next generation of digital healthcare infrastructure during this pivotal period when China’s healthcare services, distribution, and payment systems are undergoing fundamental structural transformations. This includes mobile healthcare and services primarily oriented toward primary care and innovative distribution; new payment solutions represented by commercial insurance technology; medical devices and services targeting innovation and grassroots markets; and various application directions for big data and precision diagnostics. Representative projects include: Anchor Medical, Shukun Technology, Magna Health, Zhisuan Technology, Hulian Network, Leono Medical, Beideng, Mingyi Zhonghe, Hope Group, Magna Health, Xunshi, and Credible (ASX: CRD). The partners of MARATHON have demonstrated excellent track records and unique insights throughout their investment careers: over 12 portfolio companies have gone public on domestic and international main boards or exited through mergers and acquisitions, while many others have become industry leaders. Past achievements of MARATHON's partners include BGI Genomics (SZ: 300676), MicroPoint Biotech (NEEQ: 835054), ThunderSoft (SZ: 300496), Burning Rock Biotech, Iray Technology, Annoroad, and Yi Psychology.